Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-8,427
Closed -$357K 1206
2017
Q2
$357K Sell
8,427
-36,960
-81% -$1.43M 0.01% 808
2017
Q1
$1.67M Buy
+45,387
New +$1.71M 0.03% 356
2016
Q3
Sell
-11,673
Closed -$326K 1058
2016
Q2
$326K Buy
+11,673
New +$330K 0.01% 721
2016
Q1
Sell
-88,218
Closed -$31M 971
2015
Q4
$31M Buy
+88,218
New +$3.11M 0.78% 14
2015
Q3
Sell
-42,089
Closed -$1.68M 1170
2015
Q2
$1.68M Buy
+42,089
New +$1.75M 0.05% 370
2015
Q1
Sell
-19,730
Closed -$803K 1227
2014
Q4
$803K Buy
19,730
+6,500
+49% +$277K 0.01% 748
2014
Q3
$580K Buy
+13,230
New +$603K 0.01% 927
2014
Q1
Sell
-29,362
Closed -$1.4M 1435
2013
Q4
$1.4M Buy
+29,362
New +$1.39M 0.02% 655

Other funds holding HSBC

Integral Derivatives's HSBC Position: Q2 2017 in Review

Integral Derivatives sold out of HSBC (HSBC) in Q2 2017, closing a stake of 10,045 shares — an estimated $390K sold.

Integral Derivatives first reported a position in HSBC in Q3 2014 and held it in 4 quarters. The position peaked at $1.59M in Q2 2015. 364 funds tracked by Wall St. Rank hold HSBC as of Q2 2017.

  • Integral Derivatives reported no remaining HSBC position as of Q2 2017 after selling out during the quarter.
  • Integral Derivatives sold 10,045 HSBC shares in Q2 2017, an estimated $390K.
  • Integral Derivatives first reported a position in HSBC in Q3 2014 and held it in 4 quarters.
  • Integral Derivatives's HSBC position peaked at $1.59M in Q2 2015.
  • 364 funds tracked by Wall St. Rank held HSBC as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.